José L Blaya-Cánovas, Carmen Griñán-Lisón, Isabel Blancas, Juan A Marchal, César Ramírez-Tortosa, Araceli López-Tejada, Karim Benabdellah, Marina Cortijo-Gutiérrez, M Victoria Cano-Cortés, Pablo Graván, Saúl A Navarro-Marchal, Jaime Gómez-Morales, Violeta Delgado-Almenta, Jesús Calahorra, María Agudo-Lera, Amaia Sagarzazu, Carlos J Rodríguez-González, Tania Gallart-Aragón, Christina Eich, Rosario M Sánchez-Martín, Sergio Granados-Principal
BACKGROUND: Active targeting by surface-modified nanoplatforms enables a more precise and elevated accumulation of nanoparticles within the tumor, thereby enhancing drug delivery and efficacy for a successful cancer treatment. However, surface functionalization involves complex procedures that increase costs and timelines, presenting challenges for clinical implementation. Biomimetic nanoparticles (BNPs) have emerged as unique drug delivery platforms that overcome the limitations of actively targeted nanoparticles...
May 9, 2024: Molecular Cancer